ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

Candriam S.C.A.'s Holding History (CIK: 0001537014)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 200 Value ($000) $259 Avg Close — Range —
Q1 2025
Shares 200 Value ($000) $231 Avg Close — Range —
Q4 2024
Shares 520 Value ($000) $557 Avg Close — Range —
Q3 2024
Shares 520 Value ($000) $608 Avg Close — Range —
Q2 2024
Shares 6,810 Value ($000) $6,558 Avg Close — Range —
Q1 2024
Shares 800 Value ($000) $755 Avg Close — Range —
Q4 2023
Shares 700 Value ($000) $693 Avg Close — Range —